Literature DB >> 3203034

The role of risk factors in heart attacks occurring in men with pre-existing ischaemic heart disease.

A N Phillips1, A G Shaper, S J Pocock, M Walker, P W Macfarlane.   

Abstract

The importance of three risk factors--serum total cholesterol, systolic blood pressure, and cigarette smoking--on the risk of new major ischaemic heart disease events in men who already have evidence of ischaemic heart disease was assessed. Data from the initial examination in a large prospective study of cardiovascular disease in middle aged men (the British Regional Heart Study) were used to separate 7710 men into three groups on the basis of a resting electrocardiogram, a standardised chest pain questionnaire, and recall of a doctor's diagnosis of angina or of a previous heart attack: (group 1) no evidence of ischaemic heart disease (75%), (group 2) evidence of ischaemic heart disease short of a definite myocardial infarction (20%), (group 3) definite myocardial infarction (6%). In the average follow up period of 7.5 years, 443 men suffered a new major event caused by ischaemic heart disease (fatal or non-fatal myocardial infarction or sudden cardiac death). Age standardised event rates were determined for each of the three groups for varying levels of the established risk factors. Cigarette smoking is strongly associated with the event rate in group 1 but in men with existing heart disease, especially group 3, differences in risk between the smoking categories were smaller. The strong relation between systolic blood pressure and event rate persisted in groups 1 and 2 but not in group 3. The positive association between serum concentration of total cholesterol and the event rate was strongest in group 1 and weaker in groups 2 and 3, though it remained highly significant. These observations, taken together with the results of previous prospective studies and intervention trials, suggest that the important association between serum total cholesterol and the risk of heart attack persists in men with pre-existing ischaemic heart disease, including myocardial infarction. Therefore, in these men the reduction of serum total cholesterol concentration may be at least as important as it is in men without evidence of ischaemic heart disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203034      PMCID: PMC1216598          DOI: 10.1136/hrt.60.5.404

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  16 in total

1.  Estimation of the probability of an event as a function of several independent variables.

Authors:  S H Walker; D B Duncan
Journal:  Biometrika       Date:  1967-06       Impact factor: 2.445

2.  Why measure cholesterol after myocardial infarction, and when?

Authors:  M F Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

3.  Follow-up of subjects in prospective studies based in general practice.

Authors:  M Walker; A G Shaper
Journal:  J R Coll Gen Pract       Date:  1984-07

4.  Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study.

Authors:  A G Shaper; S J Pocock; M Walker; A N Phillips; T P Whitehead; P W Macfarlane
Journal:  J Epidemiol Community Health       Date:  1985-09       Impact factor: 3.710

5.  How soon after myocardial infarction should plasma lipid values be assessed?

Authors:  R E Ryder; T M Hayes; I P Mulligan; J C Kingswood; S Williams; D R Owens
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

6.  Studies of male survivors of myocardial infarction. XII. Relation of serum lipids and lipoproteins to survival over a 10-year period.

Authors:  H M Shanoff; J A Little; A Csima
Journal:  Can Med Assoc J       Date:  1970-10-24       Impact factor: 8.262

7.  Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study.

Authors:  P H Frost; J Verter; D Miller
Journal:  Am Heart J       Date:  1987-06       Impact factor: 4.749

8.  Prevalence of ischaemic heart disease in middle aged British men.

Authors:  A G Shaper; D G Cook; M Walker; P W Macfarlane
Journal:  Br Heart J       Date:  1984-06

9.  Recall of diagnosis by men with ischaemic heart disease.

Authors:  A G Shaper; D G Cook; M Walker; P W Macfarlane
Journal:  Br Heart J       Date:  1984-06

10.  Prognostic importance of cholesterol levels after myocardial infarction.

Authors:  G Ulvenstam; R Bergstrand; S Johansson; A Vedin; C Wilhelmsson; H Wedel; A Aberg; L Wilhelmsen
Journal:  Prev Med       Date:  1984-07       Impact factor: 4.018

View more
  8 in total

1.  Cigarette smoking in British men and selection for coronary artery bypass surgery.

Authors:  R W Morris; A K McCallum; M Walker; P H Whincup; S Ebrahim; A G Shaper
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

2.  A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease.

Authors:  S Kinlay; D O'Connell; D Evans; J Halliday
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

3.  Who is for cholesterol testing?

Authors: 
Journal:  BMJ       Date:  1989-07-15

4.  Serum total homocysteine and coronary heart disease: prospective study in middle aged men.

Authors:  P H Whincup; H Refsum; I J Perry; R Morris; M Walker; L Lennon; A Thomson; P M Ueland; S B Ebrahim
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

Review 5.  Cholesterol in patients with coronary heart disease: how low should we go?

Authors:  H B Rubins
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

6.  Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease.

Authors:  S J Pocock; A G Shaper; A N Phillips
Journal:  BMJ       Date:  1989-04-15

7.  Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain.

Authors:  I J Perry; S G Wannamethee; P H Whincup; A G Shaper
Journal:  J Epidemiol Community Health       Date:  1994-12       Impact factor: 3.710

8.  Physical Stress Echocardiography: Prediction of Mortality and Cardiac Events in Patients with Exercise Test showing Ischemia.

Authors:  Ana Carla Pereira de Araujo; Bruno F de Oliveira Santos; Flavia Ricci Calasans; Ibraim M Francisco Pinto; Daniel Pio de Oliveira; Luiza Dantas Melo; Stephanie Macedo Andrade; Irlaneide da Silva Tavares; Antonio Carlos Sobral Sousa; Joselina Luzia Menezes Oliveira
Journal:  Arq Bras Cardiol       Date:  2014-10-28       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.